Healthcare -
Biotechnology - NASDAQ - US
$ 6.45
-4.02 %
$ 143 M
Market Cap
-2.96
P/E
INMB - CAPITAL EXPENDITURES
Capital Expenditures INMB - INmune Bio, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR